Certain protein kinase inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9206166
APP PUB NO 20140128387A1
SERIAL NO

14071953

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed herein are protein kinase inhibitors, more particularly novel pyrimidine derivatives and pharmaceutical compositions thereof, and method of use thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SHANGHAI FOCHON PHARMACEUTICAL CO LTD121013 NO 55 SONGSHAN STREET TAIHE DISTRICT JINZHOU CITY LIAONING PROVINCE JINZHOU CITY LIAONING PROVINCE 121013
SHANGHAI INSTITUTE OF MATERIA MEDICA CHINESE ACADEMYOF SCIENCES555 ZU CHONG ZHI ROAD SHANG JIANG HI-TECH PARK PUDONG SHANGHAI 201203

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ai, Jing Shanghai, CN 22 36
Chen, Ling Chongqing, CN 357 17312
Ding, Jian Shanghai, CN 199 1944
Geng, Meiyu Shanghai, CN 54 68
Liu, Hongbin Chongqing, CN 806 13535
Peng, Xia Shanghai, CN 15 9
Tan, Haohan Chongqing, CN 19 13
Tian, Qiang Chongqing, CN 46 34
Wang, Weibo Moraga, US 80 402
Zhang, Weipeng Chongqing, CN 32 122
Zhao, Xingdong Moraga, US 33 26

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 8, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00